Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02106364

Public ClinicalTrials.gov record NCT02106364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study

Study identification

NCT ID
NCT02106364
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Insulin Glargine Drug
  • Insulin Peglispro Drug

Drug

Eligibility (public fields only)

Age range
20 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Oct 31, 2015
Completion
May 31, 2016
Last update posted
Mar 27, 2016

2015 – 2016

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Rheumatology Associates PC Birmingham Alabama 35205
Florida Medical Clinic PA Zephyrhills Florida 33542-7505
Diagnostic Rheumatology and Research Indianapolis Indiana 46227
Heartland Research Associates Wichita Kansas 67207
Washington University Medical Center St Louis Missouri 63110
Albuquerque Rehabilitation & Rheumatology, PC Albuquerque New Mexico 87102
PMG Research of Hickory, LLC Hickory North Carolina 28602
Carolina Arthritis Associates Wilmington North Carolina 28401
STAT Research Dayton Ohio 45417
Apex Clinical Research Kennewick Washington 99336

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02106364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2016 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02106364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →